Canntab Therapeutics Limited announced earnings results for the second quarter ended November 30, 2020. For the second quarter, the company announced total revenue was CAD 378,000. Net loss was CAD 609,769 compared to CAD 623,102 a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago. For the half year, total revenue was CAD 378,000 compared to CAD 133,334 a year ago. Net loss was CAD 1.510 million compared to CAD 1.062 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.04 a year ago.